¿Los pacientes peruanos usan cannabidiol para epilepsia refractaria?: A propósito de la indicación basada en evidencia de productos derivados de marihuana / Do Peruvian patients use cannabidiol for refractory epilepsy?: About the Evidence-Based Indication of Marijuana Products
Rev. neuro-psiquiatr. (Impr.)
;
82(2): 101-103, abr. 2019.
Article
in Spanish
|
LILACS-Express
| LILACS
| ID: biblio-1058686
Full text:
Available
Index:
LILACS (Americas)
Language:
Spanish
Journal:
Rev. neuro-psiquiatr. (Impr.)
Journal subject:
Neurology
/
Psychiatry
Year:
2019
Type:
Article
Affiliation country:
Peru
Institution/Affiliation country:
Instituto Peruano de Neurociencias/PE
Similar
MEDLINE
...
LILACS
LIS